These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30473562)

  • 1. Correlation between the use of antibiotics and development of a resistant bacterial infection in patients in the ICU.
    Li Y; Xia X; Li X; Xiao K; Zhuang X
    Biosci Trends; 2018; 12(5):517-519. PubMed ID: 30473562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate.
    Lupei MI; Mann HJ; Beilman GJ; Oancea C; Chipman JG
    Surg Infect (Larchmt); 2010 Feb; 11(1):33-9. PubMed ID: 19785562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes.
    Mitharwal SM; Yaddanapudi S; Bhardwaj N; Gautam V; Biswal M; Yaddanapudi L
    Am J Infect Control; 2016 Jul; 44(7):e113-7. PubMed ID: 26944004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients).
    Vasudevan A; Mukhopadhyay A; Goh EY; Li J; Tambyah PA
    Prev Med; 2013; 57 Suppl():S70-3. PubMed ID: 23246839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of glycopeptides in intensive care?
    Esposito S; Noviello S
    J Chemother; 2003 Nov; 15 Suppl 3():11-6. PubMed ID: 14708960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surveillance of healthcare associated infections, bacterial resistance and antibiotic consumption in high-complexity hospitals in Colombia, 2011].
    Villalobos AP; Barrero LI; Rivera SM; Ovalle MV; Valera D
    Biomedica; 2014 Apr; 34 Suppl 1():67-80. PubMed ID: 24968038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels.
    Hanberger H; Antonelli M; Holmbom M; Lipman J; Pickkers P; Leone M; Rello J; Sakr Y; Walther SM; Vanhems P; Vincent JL;
    BMC Infect Dis; 2014 Sep; 14():513. PubMed ID: 25245620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study.
    Agaba P; Tumukunde J; Tindimwebwa JVB; Kwizera A
    BMC Res Notes; 2017 Jul; 10(1):349. PubMed ID: 28754148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antibiotics for the treatment of serious infections in intensive care unit patients.
    Leone S; Cascella M; Pezone I; Fiore M
    Curr Med Res Opin; 2019 Aug; 35(8):1331-1334. PubMed ID: 30760041
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic stewardship in the intensive care unit.
    Luyt CE; Bréchot N; Trouillet JL; Chastre J
    Crit Care; 2014 Aug; 18(5):480. PubMed ID: 25405992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
    Akinci E; Colpan A; Bodur H; Balaban N; Erbay A
    J Hosp Infect; 2005 Apr; 59(4):317-23. PubMed ID: 15749320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of antibiotic treatment of healthcare-associated infections at a tertiary care hospital ICU in Goa, India.
    Misal DD; Maulingkar SV; Bhonsle S
    Trop Doct; 2017 Jul; 47(3):197-201. PubMed ID: 27307475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic strategy in infections caused by resistant strains during intensive care].
    Veyssier P
    Agressologie; 1991; 32(4):225-9. PubMed ID: 1957964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bugs, hosts and ICU environment: countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting.
    Maseda E; Mensa J; Valía JC; Gomez-Herreras JI; Ramasco F; Samso E; Chiveli MA; Pereira J; González R; Aguilar G; Tamayo G; Ojeda N; Rico J; Gimenez MJ; Aguilar L
    Rev Esp Quimioter; 2013 Dec; 26(4):312-31. PubMed ID: 24399345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial.
    van Duijn PJ; Verbrugghe W; Jorens PG; Spöhr F; Schedler D; Deja M; Rothbart A; Annane D; Lawrence C; Nguyen Van JC; Misset B; Jereb M; Seme K; Šifrer F; Tomiç V; Estevez F; Carneiro J; Harbarth S; Eijkemans MJC; Bonten M;
    Lancet Infect Dis; 2018 Apr; 18(4):401-409. PubMed ID: 29396000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting.
    Marra AR; de Almeida SM; Correa L; Silva M; Martino MD; Silva CV; Cal RG; Edmond MB; dos Santos OF
    Am J Infect Control; 2009 Apr; 37(3):204-9. PubMed ID: 18986735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
    Bonten MJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.